« A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease ». One Health & Risk Management 4, no. 4 (septembre 29, 2023): 19–26. Consulté le juillet 11, 2026. https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/374.